Weida Gong

Weida Gong

Auto-generated profile, based on publicly available information

Weida Gong

Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Cancer Research
Verified
Journal Article
Closed access
DWDaoyan Wei
Daoyan Wei
WGWeida Gong
Weida Gong
MKMasashi Kanai
Masashi Kanai
CSChristian Schlunk
Christian Schlunk
LWLiwei Wang
Liwei Wang
KXKeping Xie
Keping Xie
Krüppel-like factor 4 (KLF4) is highly expressed in epithelial tissues such as the gut and skin. However, the role of KLF4 in human gastric cancer development and progression is unknown. Here we show that KLF4 protein expression was decreased or lost in primary tumors and, in particular, lymph node metastases when compared with that in normal gastric mucosa. Moreover, loss of KLF4 expression in the primary tumors was significantly associated with poor survival, and also an independent prognostic marker in a multivariate analysis. Consistently, most human gastric cancer cell lines exhibited loss of or a substantial decrease in KLF4 expression at both RNA and protein levels. Enforced restoration of KLF4 expression resulted in marked cell growth inhibition in vitro and significantly attenuated tumor growth and total abrogation of metastasis in an orthotopic animal model of gastric cancer. Mechanism studies indicated that promoter hypermethylation and hemizygous deletion contributed to the down-regulation of KLF4 expression and the induction of apoptosis contributed to the antitumor activity of KLF4. Collectively, our data provide first clinical and casual evidence and potential mechanism that the alteration of KLF4 expression plays a critical role in gastric cancer development and progression.

1 December 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
BCBinita Chakraborty
Binita Chakraborty
JBJovita Byemerwa
Jovita Byemerwa
JSJonathan Shepherd
Jonathan Shepherd
CHCorinne N. Haines
Corinne N. Haines
RBRobert Baldi
Robert Baldi
DMDonald P McDonnell
Donald P McDonnell
Immune checkpoint blockade (ICB) therapies have significantly prolonged patient survival across multiple tumor types, particularly in melanoma. Interestingly, sex-specific differences in response to ICB have been observed, with males receiving a greater benefit from ICB than females, although the mechanism or mechanisms underlying this difference are unknown. Mining published transcriptomic data sets, we determined that the response to ICBs is influenced by the functionality of intratumoral macrophages. This puts into context our observation that estrogens (E2) working through the estrogen receptor α (ERα) stimulated melanoma growth in murine models by skewing macrophage polarization toward an immune-suppressive state that promoted CD8+ T cell dysfunction and exhaustion and ICB resistance. This activity was not evident in mice harboring macrophage-specific depletion of ERα, confirming a direct role for estrogen signaling within myeloid cells in establishing an immunosuppressed state. Inhibition of ERα using fulvestrant, a selective estrogen receptor downregulator (SERD), decreased tumor growth, stimulated adaptive immunity, and increased the antitumor efficacy of ICBs. Further, a gene signature that determines ER activity in macrophages predicted survival in patients with melanoma treated with ICB. These results highlight the importance of E2/ER signaling as a regulator of intratumoral macrophage polarization, an activity that can be therapeutically targeted to reverse immune suppression and increase ICB efficacy.

2 November 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HFHuitao Fan
Huitao Fan
JLJiuwei Lu
Jiuwei Lu
YGYiran Guo
Yiran Guo
DLDongxu Li
Dongxu Li
ZZZhi-Min Zhang
Zhi-Min Zhang
Greg WangGreg Wang
Greg Wang

8 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
SZShuai Zhao
Shuai Zhao
JLJiuwei Lu
Jiuwei Lu
BPBo Pan
Bo Pan
HFHuitao Fan
Huitao Fan
SBStephanie Byrum
Stephanie Byrum
Greg WangGreg Wang
Greg Wang
Trimethylation of histone H3 lysine 9 (H3K9me3) is crucial for the regulation of gene repression and heterochromatin formation, cell-fate determination and organismal development1. H3K9me3 also provides an essential mechanism for silencing transposable elements1,2,3,4. However, previous studies have shown that canonical H3K9me3 readers (for example, HP1 (refs. 5,6,7,8,9) and MPP8 (refs. 10,11,12)) have limited roles in silencing endogenous retroviruses (ERVs), one of the main transposable element classes in the mammalian genome13. Here we report that trinucleotide-repeat-containing 18 (TNRC18), a poorly understood chromatin regulator, recognizes H3K9me3 to mediate the silencing of ERV class I (ERV1) elements such as LTR12 (ref. 14). Biochemical, biophysical and structural studies identified the carboxy-terminal bromo-adjacent homology (BAH) domain of TNRC18 (TNRC18(BAH)) as an H3K9me3-specific reader. Moreover, the amino-terminal segment of TNRC18 is a platform for the direct recruitment of co-repressors such as HDAC–Sin3–NCoR complexes, thus enforcing optimal repression of the H3K9me3-demarcated ERVs. Point mutagenesis that disrupts the TNRC18(BAH)-mediated H3K9me3 engagement caused neonatal death in mice and, in multiple mammalian cell models, led to derepressed expression of ERVs, which affected the landscape of cis-regulatory elements and, therefore, gene-expression programmes. Collectively, we describe a new H3K9me3-sensing and regulatory pathway that operates to epigenetically silence evolutionarily young ERVs and exert substantial effects on host genome integrity, transcriptomic regulation, immunity and development.

8 November 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
XLXijuan Liu
Xijuan Liu
JWJun Wang
Jun Wang
JBJoshua A. Boyer
Joshua A. Boyer
WGWeida Gong
Weida Gong
SZShuai Zhao
Shuai Zhao
QZQING ZHANG
QING ZHANG

16 August 2018 in Environmental Microbiology
Verified
Journal Article
Closed access
PDF file
NCNatalie R Cohen
Natalie R Cohen
WGWeida Gong
Weida Gong
DMDawn M. Moran
Dawn M. Moran
MMMatthew R. McIlvin
Matthew R. McIlvin
MSMak A. Saito
Mak A. Saito
AMAdrian Marchetti
Adrian Marchetti